title: The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy.
abstract: BACKGROUND
  Adiponectin directly protects against cardiac remodeling. Despite this beneficial effect, most epidemiological studies have reported a negative relationship between adiponectin level and left ventricular mass index (LVMI). However, a positive relationship has also been reported in subjects at high risk of left ventricular hypertrophy (LVH). Based on these conflicting results, we hypothesized that the relationship between serum adiponectin level and LVMI varies with the risk of LVH.
  
  
  METHODS
  A community-based, cross-sectional study was performed on 1414 subjects. LVMI was measured by echocardiography. Log-transformed adiponectin levels (Log-ADPN) were used for the analysis.
  
  
  RESULTS
  Serum adiponectin level had a biphasic distribution (an increase after a decrease) with increasing LVMI. Although Log-ADPN did not correlate with LVMI, Log-ADPN was modestly associated with LVMI in the multivariate analysis (β = 0.079, p = 0.001). The relationship between adiponectin level and LVMI was bidirectional according to the risk of LVH. In normotensive subjects younger than 50 years, Log-ADPN negatively correlated with LVMI (r = -0.204, p = 0.005); however, Log-ADPN positively correlated with LVMI in ≥50-year-old obese subjects with high arterial stiffness (r = 0.189, p = 0.030). The correlation coefficient between Log-ADPN and LVMI gradually changed from negative to positive with increasing risk factors for LVH. The risk of LVH significantly interacted with the relationship between Log-ADPN and LVMI. In the multivariate analysis, Log-ADPN was associated with LVMI in the subjects at risk of LVH; however, Log-ADPN was either not associated or negatively associated with LVMI in subjects at low risk of LVH.
  
  
  CONCLUSIONS
  Adiponectin level and LVMI are negatively associated in subjects at low risk of LVH and are positively associated in subjects at high risk of LVH. Therefore, the relationship between adiponectin and LVMI varies with the risk of LVH.
authors.affiliation: Department of Cardiology, Hanyang University Hospital, Seoul, Republic of Korea ; Cardiology Clinic, Myungji St. Mary's Hospital, Seoul, Republic of Korea.
authors.forename: Yonggu
authors.initials: Y
authors.lastname: Lee
authors.forename: Bae Keun
authors.initials: BK
authors.lastname: Kim
authors.forename: Young-Hyo
authors.initials: YH
authors.lastname: Lim
authors.forename: Mi Kyung
authors.initials: MK
authors.lastname: Kim
authors.forename: Bo Youl
authors.initials: BY
authors.lastname: Choi
authors.forename: Jinho
authors.initials: J
authors.lastname: Shin
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000368:Aged; D001794:Blood Pressure / Q000502:physiology; D003430:Cross-Sectional Studies; D004452:Echocardiography; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000097:blood*; D008297:Male; D008875:Middle Aged
chemical_list: D052242:Adiponectin
references.citation: Heart Fail Rev. 2010 Sep;15(5):457-66
references.pmid: 20204504
references.citation: Nephron Clin Pract. 2007;107(3):c103-8
references.pmid: 17890872
references.citation: J Biomed Sci. 2008 Sep;15(5):565-76
references.pmid: 18535923
references.citation: J Cell Physiol. 2010 Jan;222(1):149-55
references.pmid: 19780028
references.citation: Circulation. 2010 Feb 23;121(7):e46-e215
references.pmid: 20019324
references.citation: Heart. 2011 Apr;97(8):648-54
references.pmid: 21330312
references.citation: Hypertension. 2007 Jun;49(6):1448-54
references.pmid: 17420337
references.citation: Eur Heart J. 2008 May;29(9):1168-80
references.pmid: 18390538
references.citation: Br J Nutr. 2010 Oct;104(8):1202-11
references.pmid: 20487581
references.citation: Nat Med. 2004 Dec;10(12):1384-9
references.pmid: 15558058
references.citation: Metab Syndr Relat Disord. 2012 Aug;10(4):297-306
references.pmid: 22545589
references.citation: Am J Med Sci. 2013 Jun;345(6):455-61
references.pmid: 23123561
references.citation: Biochem Biophys Res Commun. 2010 Mar 12;393(3):519-25
references.pmid: 20152812
references.citation: Circulation. 2005 Sep 20;112(12):1756-62
references.pmid: 16157772
references.citation: J Nephrol. 2009 Mar-Apr;22(2):216-23
references.pmid: 19384839
references.citation: J Hum Hypertens. 2007 Jul;21(7):546-50
references.pmid: 17392814
references.citation: J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
references.pmid: 16376782
references.citation: J Clin Invest. 2006 Jul;116(7):1784-92
references.pmid: 16823476
references.citation: J Intern Med. 2010 Oct;268(4):338-47
references.pmid: 20649935
references.citation: J Hypertens. 2000 Aug;18(8):1121-8
references.pmid: 10954005
references.citation: Nephrol Dial Transplant. 2007 Apr;22(4):981-8
references.pmid: 17234664
references.citation: Circ Heart Fail. 2011 Nov;4(6):747-53
references.pmid: 21840935
references.citation: J Am Coll Cardiol. 2009 Jun 2;53(22):2070-7
references.pmid: 19477358
references.citation: Blood Press. 2004;13(4):236-42
references.pmid: 15581338
references.citation: J Am Coll Cardiol. 2009 Mar 3;53(9):754-62
references.pmid: 19245965
references.citation: Circ J. 2007 May;71(5):623-30
references.pmid: 17456982
references.citation: Clin Transplant. 2011 Jul-Aug;25(4):561-8
references.pmid: 20964715
references.citation: Ann Med. 2010 Mar;42(2):131-7
references.pmid: 20166815
references.citation: Endocr J. 2008 Jul;55(3):523-8
references.pmid: 18469485
references.citation: Lipids Health Dis. 2012 Aug 30;11:106
references.pmid: 22935137
references.citation: Heart Fail Rev. 2013 Sep;18(5):631-44
references.pmid: 22893246
references.citation: Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H690-8
references.pmid: 20622112